aTyr Pharma Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for aTyr Pharma stock have an average target of 18.6, with a low estimate of 9.00 and a high estimate of 35. The average target predicts an increase of 515.89% from the current stock price of 3.02.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$9.00	$18.6	$16	$35
Change	+198.01%	+515.89%	+429.80%	+1058.9%

Analyst Ratings

The average analyst rating for aTyr Pharma stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	2	2
Buy	2	2	2	3	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	5	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $35	Strong Buy	Reiterates	$35	+1,058.94%	Mar 14, 2025
Faisal Khurshid Leerink Partners	Leerink Partners	Buy Initiates $16	Buy	Initiates	$16	+429.80%	Feb 18, 2025
Prakhar Agrawal Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Jan 6, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $35	Strong Buy	Reiterates	$35	+1,058.94%	Dec 10, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $35	Strong Buy	Reiterates	$35	+1,058.94%	Dec 3, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

3.50M

from 235.00K

1,387.23%

from 235.00K

Revenue Next Year

34.01M

from 3.50M

873.22%

from 3.50M

EPS This Year

-0.72

from -0.86

EPS Next Year

-0.53

from -0.72

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	10.46M	-	10.39M	353.00K	235.00K	3.50M	34.01M	165.45M
Revenue Growth	2,377.49%	-	-	-96.60%	-33.43%	1,387.23%	873.22%	386.42%
EPS	-1.77	-1.77	-1.60	-0.94	-0.86	-0.72	-0.53	0.15
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	20.07
No. Analysts	-	-	-	-	-	13	13	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	25.6M	123.9M	328.7M
Avg	3.5M	34.0M	165.5M
Low	n/a	n/a	19.6M

Revenue Growth

Revenue Growth	2025	2026	2027
High	10,814.0%	3,445.1%	866.2%
Avg	1,387.2%	873.2%	386.4%
Low	-	-	-42.4%

EPS Forecast

EPS	2025	2026	2027
High	-0.60	0.29	1.08
Avg	-0.72	-0.53	0.15
Low	-0.90	-1.23	-0.81

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.